Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets: 2014-2016
Historic Current Deferred Tax Assets for Enanta Pharmaceuticals (ENTA) over the last 2 years, with Jun 2016 value amounting to $1.1 million.
- Enanta Pharmaceuticals' Current Deferred Tax Assets fell 34.72% to $1.1 million in Q2 2016 from the same period last year, while for Jun 2016 it was $1.1 million, marking a year-over-year decrease of 34.72%. This contributed to the annual value of $1.4 million for FY2015, which is 86.99% down from last year.
- Per Enanta Pharmaceuticals' latest filing, its Current Deferred Tax Assets stood at $1.1 million for Q2 2016, which was down 27.45% from $1.6 million recorded in Q1 2016.
- Enanta Pharmaceuticals' Current Deferred Tax Assets' 5-year high stood at $11.2 million during Q2 2014, with a 5-year trough of $1.1 million in Q2 2016.
- Its 3-year average for Current Deferred Tax Assets is $3.6 million, with a median of $1.6 million in 2016.
- The largest annual percentage gain for Enanta Pharmaceuticals' Current Deferred Tax Assets in the last 5 years was 17.28% (2015), contrasted with its biggest fall of 86.99% (2015).
- Quarterly analysis of 3 years shows Enanta Pharmaceuticals' Current Deferred Tax Assets stood at $1.3 million in 2014, then climbed by 17.28% to $1.6 million in 2015, then tumbled by 34.72% to $1.1 million in 2016.
- Its Current Deferred Tax Assets stands at $1.1 million for Q2 2016, versus $1.6 million for Q1 2016 and $1.6 million for Q4 2015.